A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also may preserve fertility, according to results of a new study conducted by Johns Hopkins Kimmel Cancer Center investigators. The work is published in the journal Blood Advances.
This article was originally published on MedicalXpress.com

